ENvue Medical, Inc. FEED
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2015-04-24
ENvue Medical, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.6M | $2.6M | $2.3M | $752,000 | $1.7M |
| Gross profit | $153,000 | $1.5M | $1.5M | $167,000 | $770,000 |
| R&D expense | $1.8M | $909,000 | $185,000 | $283,000 | $293,000 |
| Operating income | -$22.9M | -$3.6M | -$3.4M | -$5.0M | -$5.7M |
| Interest expense | — | $135,000 | $135,000 | $347,000 | — |
| Income tax | -$307,000 | $19,000 | $29,000 | $35,000 | $32,000 |
| Net income | -$18.2M | -$3.7M | -$3.7M | -$5.4M | -$14.3M |
| EPS (diluted) | $-26.69 | $-137.30 | $-23.32 | $-3.84 | — |
| Operating cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Free cash flow | -$9.4M | -$2.5M | -$3.6M | -$7.0M | -$4.4M |
| Cash & equivalents | $4.2M | $752,000 | — | — | $7.7M |
| Inventory | $2.3M | $2.2M | $2.7M | $2.2M | $175,000 |
| Total assets | $41.1M | $3.6M | $6.7M | $5.9M | $8.6M |
| Total liabilities | $7.6M | $3.0M | $2.7M | $2.6M | $2.3M |
| Shareholders' equity | $33.5M | $627,000 | $4.0M | $3.2M | $6.3M |
Source: SEC EDGAR filings · CIK 0001326706 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.